fbpx

VAI-SU2C Epigenetics Dream Team

31 results.

VAI DEFAULT HEADER
October 12, 2017 A Catalyst for combating cancer

Nearly $5.5 million in grant funding to fuel collaborative clinical trials in lung and bladder cancers By Dr. Peter Jones and Dr. Steve Baylin Co-leaders,…

October 12, 2017 Stand Up To Cancer awards $5.5 million to VARI for cancer clinical trials to enhance immunotherapy

GRAND RAPIDS, Mich. (Oct. 12, 2017)—Van Andel Research Institute–Stand Up To Cancer Epigenetics Dream Team (VARI-SU2C) scientists have been awarded two…

June 13, 2017 VARI-SU2C Epigenetics Dream Team launches new clinical trial to combat blood cancers

GRAND RAPIDS, Mich. (June 13, 2017)—A new clinical trial spanning three cancer centers in California, Maryland and Pennsylvania is investigating a promising…

March 7, 2017 New drug combination targets aggressive blood cancer

Safety and efficacy of combining talazoparib with decitabine to treat acute myeloid leukemia (AML) are subject of multi-site clinical trial GRAND RAPIDS, Mich. (March 7,…

March 2, 2017 Three things to know about colorectal cancer

March marks Colorectal Cancer Awareness Month, a time to share information and raise awareness about these devastating diseases. Here are three key…

December 30, 2016 What difference does a year make?

When it comes to biomedical research and science education, a year can make all the difference. In 2016, we celebrated Van Andel…

October 10, 2016 Combinations and collaborations in the fight against cancer: An interview with Dr. Feyruz Rassool and Dr. Stephen Baylin

What happens when scientists collaborate rather than compete? In this case, the result is a combination of two drugs that may be a more effective…